ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice

Lin, Chuangzhen; Yu, Bingqing; Chen, Lixin; Zhang, Zhaohui; Ye, Weixiang; Zhong, Hui; Bai, Wenke; Yang, Yuping; Nie, Biao*南方医科大学; 1
Frontiers in Pharmacology2022-5-9DOI: 10.3389/fphar.2022.880508
5被引9阅读
引用收藏
分享

摘要

Objective: Obeticholic acid (OCA), a potent farnesoid X receptor (FXR) agonist, is a promising drug for nonalcoholic fatty liver disease (NAFLD); however, it can cause liver injury, especially at high doses. Here, we investigated the role of FXR in the high-dose OCA-induced hepatoxicity in the condition of the NAFLD mouse model. Methods: Wild-type (WT) mice and FXR-/- mice were administered with over-dose OCA (0.40%) and high-dose OCA (0.16%), in a high-fat diet. RNA-seq on liver samples of mice fed with high-dose OCA was performed to dig out the prominent biological events contributing to hepatic fibrosis. Results: Over-dose OCA induced liver injury and shortened survival in WT mice, but not FXR-/- mice. High-dose OCA caused hepatic stellate cell activation and liver fibrosis in the presence of FXR. Furthermore, high-dose OCA induced cholesterol accumulation in livers via the upregulation of genes involved in cholesterol acquisition and downregulation of genes regulating cholesterol degradation in liver, leading to the production of interleukin-1 beta and an FXR-mediated inflammatory response. Conclusion: The high-dose OCA induced FXR-dependent hepatic injury via cholesterol accumulation and interleukin-1 beta pathway in the NAFLD mice.

学科与关键词

关键词
nonalcoholic fatty liver disease (NAFLD)obeticholic acid (OCA)farnesoid X receptor (FXR)hepatic fibrosisinterleukin-1 beta
相关
加载中…
  • Obeticholic acid inhibits hepatic fatty acid uptake independent of FXR in mouse
    Lin, Chuangzhen; Yu, Bingqing; Liu, Xuelian; Chen, Lixin; Zhang, Zhaohui; Ye, Weixiang; Zhong, Hui; Bai, Wenke; Yang, Yuping; Nie, Biao*Biomedicine and Pharmacotherapy, 2022, 150: 112984.被引 2
  • Obeticholic acid improved triptolide/lipopolysaccharide-induced hepatotoxicity by inhibiting caspase-11-GSDMD pyroptosis pathway
    Liang, Peishi; Zhou, Shaoyun; Yuan, Ziqiao; Zhang, Luyong; Jiang, Zhenzhou*; Yu, Qinwei*Journal of Applied Toxicology, 2023, 43(4): 599-614.被引 2
  • Obeticholic acid aggravates liver injury by up-regulating the liver expression of osteopontin in obstructive cholestasis
    Wang, Jie; Yuan, Zihang; Zhang, Haoran; Wu, Qipeng; Miao, Yingying; Xu, Yunxia; Yu, Qinwei; Huang, Xiaofei; Zhang, Ziling; Huang, Xinliang; Tang, Qianhui; Zhang, Luyong*; Jiang, Zhenzhou*Life Sciences, 2022, 307: 120882.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-05-09
卷期
第 13 卷
页码
880508
DOI
10.3389/fphar.2022.880508
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Scientific Research Foundation for Returned Scholars of the Ministry of Education of China; National Natural Science Foundation of China [81471080]

作者

  • L

    Lin, Chuangzhen (第一作者)

    1

  • Y

    Yu, Bingqing

    1

查看全部 9 位作者收起作者
  • C

    Chen, Lixin

    1

  • Z

    Zhang, Zhaohui

    1

  • Y

    Ye, Weixiang

    1

  • Z

    Zhong, Hui

    southern med univ

  • B

    Bai, Wenke

    1

  • Y

    Yang, Yuping

    1

  • N

    Nie, Biao (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417